Endocrine Regulations (Jul 2022)

Impact of hydrocortisone replacement on bone mineral density and bone turnover markers in patients with primary adrenal insufficiency

  • Yazidi Meriem,
  • Danguir Cyrine,
  • Maamer Dhouha,
  • Oueslati Ibtissem,
  • Khiari Karima,
  • Elleuch Mohamed,
  • Feki Moncef,
  • Chihaoui Melika

DOI
https://doi.org/10.2478/enr-2022-0022
Journal volume & issue
Vol. 56, no. 3
pp. 209 – 215

Abstract

Read online

Objective. The study was aimed to assess the effect of hydrocortisone (HC) replacement therapy on bone mineral density (BMD) and bone turnover markers in patients with primary adrenal insufficiency (PAI).

Keywords